K

Keros Therapeutics

Develops TGF-ß signaling-modulating therapeutics

Director of Clinical Sciences

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeLexington, MA, USA$200k - $241k

About the Job

Requirements

  • Genuine interest in and understanding of the science supporting the pipeline.
  • Ability to work collaboratively in a highly matrixed, multidisciplinary team setting and drive innovation to help the organization succeed.
  • Strong leadership and communication skills, with proven proficiency in understanding, analyzing, and presenting scientific and clinical data.
  • Detailed understanding of clinical trial design, methodology, statistical concepts, protocol development and implementation, global regulatory submissions, and overall drug development.
  • Working knowledge of the IND/NDA process.
  • Ability to engage and collaborate with diverse internal and external stakeholders, including executive leadership, study investigators, key opinion leaders, and the external medical and scientific community.
  • Ability to work in the company office at least 2–3 times per week.
  • Ability to travel up to 20%.
  • A doctorate (MD, PhD, PharmD, or equivalent) is required.
  • At least 5 years of clinical development experience in the pharmaceutical or biotechnology industry.

Responsibilities

  • Serve as the lead Clinical Scientist for the KER-065 program or another assigned program and represent clinical sciences in cross-functional team meetings.
  • Lead and support creation of key documents, including clinical trial protocols, investigator brochures, clinical study reports, regulatory documents such as INDs/CTAs and NDAs/MAAs, and regulatory responses, ensuring quality and consistency with the Clinical Development Plan.
  • Collaborate with biostatistics, clinical development, and other team members on timely data analyses and presentations for safety monitoring committee meetings, regulatory documents, and internal reviews to support program decisions regarding study objectives.
  • Contribute to study medical and safety aspects and risk-benefit assessments in close collaboration with the Pharmacovigilance team.
  • Plan and lead ongoing medical data review in collaboration with data management and other functions.
  • Work with Clinical Operations to support patient-centric drug development while balancing medical quality, trial complexity, time, and cost considerations.
  • Own and ensure preparation of clinical sections of key documents, including investigator brochures, IND summary documents, CTAs, responses to regulatory authorities, IRBs and ethics committees, and NDAs.
  • Contribute medical content to clinical study reports and provide guidance to other team members as needed.
  • Work with the internal team to develop and update key messages on disease states, mechanism of action, target product profile, and scientific platform.
  • Collaborate with Medical Affairs and other team members on scientific communication of clinical data, including external messaging, publication planning, and congress management.
  • Author and review abstracts, posters, and manuscripts for publication.
  • Lead, contribute to, and drive initiatives based on functional goals and corporate objectives.

Desired Qualifications

  • Direct experience with NDA/BLA filings.
  • Experience developing therapies for neuromuscular or neurodegenerative indications.

About the Company

Keros Therapeutics

Develops TGF-ß signaling-modulating therapeutics

Keros Therapeutics focuses on developing therapies that target the transforming growth factor-beta (TGF-ß) signaling pathway to treat diseases linked to its dysfunction. Its products aim to modulate TGF-ß signaling to influence cellular growth and repair, with the goal of altering disease progression and providing disease-modifying benefits, especially in blood cells and tissues. The company advances therapeutics through research and development, with commercialization as its end goal once therapies are approved for patients. What sets Keros apart is its specialized expertise in TGF-ß biology and its emphasis on creating drugs that directly modulate this signaling network to produce meaningful clinical outcomes. The overall goal is to bring therapies to market that improve patient outcomes by correcting or adjusting TGF-ß-related signaling in relevant diseases.

Company size
51-200
Company stage
IPO
Headquarters
Lexington, KY
Founded
2015

Recently Posted Jobs

Explore more opportunities at Keros Therapeutics

See more jobs